New Treatment Approved for Rare Disease PKU

FRIDAY, May 25, 2018 — Palynziq (pegvaliase-pqpz) has been approved by the U.S. Food and Drug Administration to treat phenylketonuria, commonly called PKU.
People with the rare yet serious inherited disorder can’t break down an amino acid called…
Source: Topamax